Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Significant methodological deficiencies
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
publication
Title:
Tierexperimentelle Untersuchungen zur Toxizität des Bariumstearates
Author:
Schmidt, P. et al.
Year:
1975
Bibliographic source:
Zeitschrift für die gesamte Hygiene und ihre Grenzgebiete 21: 613 - 617.

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
adopted 1981-05-12
Deviations:
yes
Remarks:
observation period after test item administration to short; information on dose levels, concentrations, strain of rats and age of rats & on the examination of the animals were not provided; information if dead animals were observed was missing
GLP compliance:
not specified
Test type:
standard acute method

Test material

Constituent 1
Reference substance name:
Barium stearate
IUPAC Name:
Barium stearate
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder

Test animals

Species:
rat
Strain:
not specified
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: from own institute random breeding
- Weight at study initiation: 199 g (175 - 210 g)
- Fasting period before study: 18 hours before administration of the test substance
- Housing: in groups of 10 rats
- Diet: pelletised standard feed (Sorte K) of the Staatlichen Zentralstelle für Versuchstierzucht und - versorgung Berlin
- Water (ad libitum)

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
peanut oil
Details on oral exposure:
no data
Doses:
6 doses (the number of doses was derived from the total number of animals divided by the number of animals used per dose; the doses were not further described)
No. of animals per sex per dose:
15 female rats
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 2 days
- Frequency of observations and weighing: the examination of the surviving animals were conducted from 8:00 to 12:00 o'clock, if not otherwise stated.
- The animals were killed through exsanguination after etherisation.
Statistics:
The lethal dose was calculated according to Litchfield and Wilcoxon (1949)*

* Reference:
Litchfiled, jr., I.T., and W.F. Wilcoxon: J. Pharmacol. exper. Therapeut. 96 (1949), 99.

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50
Effect level:
3 400 mg/kg bw
Based on:
test mat.
95% CL:
2 075 - 3 800
Remarks on result:
other: LD50 of barium stearate was calculated 2 days after study initiation
Sex:
female
Dose descriptor:
LD50
Effect level:
646 mg/kg bw
Based on:
element
95% CL:
505 - 740
Remarks on result:
other: LD50 of barium was calculated 2 days after study initiation.
Mortality:
no data
Clinical signs:
other: no data
Gross pathology:
no data

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
LD50 (female rats): 3400 mg barium stearate/kg
LD50 (female rats): 646 mg barium/kg
According to the EC-Commission directive 67/548/EEC and its subsequent amendments, the test substance is not classified as acute toxic via the oral route.
According to the EC-Regulation 1272/2008 and subsequent regulations, the test item is not classified as acute toxic via the oral route.